Industry context
Envoy Medical Inc [COCH]
Last Updated 24 Jun 2026 @ 16:00 (Exchange is closed)
Last: $0.631
-2.94%
-3.67
GaG Algo Score™
v1.0
Short
-3.67
Medium
-5.59 (↓)
Long
-5.28 (↑)
Line
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 44.23% | 29.98% | 41.29% |
| Loss % | -28.03% | -22.00% | 18.53% |
| Duration | 17.9d | 19d | 10.4d |
| Total Pivots Found | 15 |
| Gain/Loss Legs | 14 (7 Gain / 7 Loss) |
| Last Pivot | Bottom @ $0.62 on 2026-06-09 |
| Change since Last Pivot | $0.01 (1.76%) |
Next Pivot Prediction Last: $0.63
| Predicted Next Type | Top |
| Predicted Price (Avg) | $0.89 |
| Predicted Price (Median) | $0.81 |
| Predicted Price Range (~68%) | $0.64 - $1.15 |
| Change to Avg Target | $0.26 (41.74%) |
| Predicted Date (Avg) | 2026-06-26 |
| Predicted Date Range (~68%) | 2026-06-16 - 2026-07-07 |
| Basis | Based on 7 historical gains (Avg: 44.23%, Median: 29.98%, StdDev: 41.29%) and duration (Avg: 17.9 days, StdDev: 10.4 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Envoy Medical Inc fell moderately, down -2.94% on Wednesday.
Envoy Medical Inc (COCH) stock price experienced a moderate pullback on Wednesday after the stock fell $-0.0191 (-2.94%) from the previous session on below-average volume. The stock fell slightly more than the NASDAQ which was down -0.43%. Yesterday's trading volume was 73 175 shares, worth about $46 166. This represents 29 925 shares less than the day before. Volume was below the 10-day average of 124 662 shares.
Envoy Medical Inc signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-46.7%), medium- (-46.7%), and long-term (-46.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Envoy Medical Inc Support & Resistance Levels
The stock is trading above the closest support level at $0.630. approximately $0.000900 (0.14%) away. This suggests it is currently acting as a floor, pushing down towards support.The sup dis das support s10.63 -
Envoy Medical Inc Evaluation
- Short score: -3.67
- Medium score: -5.59
- Long score: -5.28
Ownership flow
GetAGraph InsiderPower
Transactions
64
Buy power
25.54M
Sell power
6.88M
Reliability
100/100
Buy / sell
3.71
Hist. corr.
0.04
Latest signal
Sell 2026-06-18
Director 42
Officer 17
Major holder 6
2027-12-31
Barclays Plc Major holder
Other 333 019
2026-06-19
Lucas Brent T. Officer
Buy 1 000 000
2026-05-29
Lucas Brent T. Officer
Buy 32 856
2026-04-15
Mckhann Chas Director
Buy 100 000
2026-04-15
Mckhann Chas Director
Other
2026-04-15
Mckhann Chas Director
Buy 100 000
Event context
Volume and dividends
Long volume corr.
-0.01
Short volume corr.
-0.39
Positioning pressure
Short interest pressure
Short interest
5.54%
Of outstanding shares
Short float
10.61%
Of tradable float
Days to cover
8.68
Short interest divided by average volume
Squeeze probability
23.90%
-8.37% change
Short positioning is elevated and could amplify sharp price moves.
Updated 2026-05-29Earnings quality
Earnings history
Reported quarters
11
EPS beats
1
EPS misses
5
Avg. surprise
-28.04%
| Period | Date | Actual EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3/2025 | 2025-08-11 | - | $-0.300 | - | - |
| Q2/2025 | 2025-05-01 | $-0.290 | $-0.350 | 17.14% | 46 000 |
| Q1/2025 | 2025-03-28 | $-0.450 | $-0.330 | -36.36% | 42 000 |
| Q4/2024 | 2024-11-14 | $-0.370 | $-0.270 | -37.04% | 56 000 |
| Q3/2024 | 2024-08-12 | $-0.270 | $-0.240 | -12.50% | 68 000 |
| Q2/2024 | 2024-05-15 | $-0.320 | $-0.190 | -68.42% | 59 000 |
| Q1/2024 | 2024-03-29 | $-0.249 | $-0.190 | -31.07% | 59 000 |
| Q3/2023 | 2023-11-17 | $0.130 | - | - | 80 000 |
Analyst view
Analyst targets
Consensus
$6.00
Median
$6.00
Low
$6.00
High
$6.00
News flow
Latest company news
Market coverage
newsfilecorp.com Envoy Medical to Present at Investor Conferences on June 25th Jun 18, 2026 newsfilecorp.com Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th Jun 4, 2026 newsfilecorp.com Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology May 20, 2026 newsfilecorp.com Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant May 11, 2026Company releases
Company context
Company profile
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Currency
USD
Envoy Medical Inc is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss Its diverse product portfolio includes conventional hearing aids Esteem middle ear implants bone conduction devices and Acclaim cochlear implants Established in 1995 the company originally operated as St Croix Medical Inc before officially rebranding to Envoy Medical Inc in December 2004 Envoy Medical Inc is headquartered in White Bear Lake Minnesota
Navigation